Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Henna and Shirazi thyme for treatment of cutaneous leishmaniasis
IRCT20150105020570N3Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- May 2018
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of henna and zataria multiflora in cutaneous leishmaniasis (CL), sponsored by Shiraz University of Medical Sciences. Started May 2018; status: completed.
02
Drugs
hennazataria multiflora
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on IRCT20150105020570N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150105020570N3.